[ALNY] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -15.82%
YoY- -38.12%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 220,553 103,962 44,714 29,907 15,932 8,709 8,685 71.36%
PBT -188,331 -177,903 -218,521 -163,481 -118,420 -90,129 -71,352 17.54%
Tax 1,228 1,326 960 79 -2,577 -2,092 431 19.04%
NP -189,559 -179,229 -219,481 -163,560 -118,420 -90,129 -71,783 17.55%
Tax Rate - - - - - - - -
Total Cost 410,112 283,191 264,195 193,467 134,352 98,838 80,468 31.15%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -85.95 -172.40 -490.86 -546.90 -743.28 -1,034.89 -826.52 -31.40%
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -1.61 -1.56 -2.02 -1.63 -1.34 -1.05 -0.85 11.22%
EPS Diluted -1.61 -1.56 -2.02 -1.63 -1.34 -1.05 -0.85 11.22%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.